Status:
COMPLETED
Study Evaluating TwoTablet Formulations of Neratinib (HKI-272)
Lead Sponsor:
Puma Biotechnology, Inc.
Conditions:
Healthy Subjects
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
This study will examine the bioavailability (the rate and extent to which the active ingredient or active moiety is absorbed from a drug product and becomes available at the site of action) of two tab...
Eligibility Criteria
Inclusion
- Healthy male and female subjects, ages 18-50.
Exclusion
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00814060
Start Date
January 1 2009
End Date
March 1 2009
Last Update
May 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tacoma, Washington, United States, 98418